Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02162433 · ClinicalTrials.gov registry record · Phase 4
The Effect of Dexmedetomidine on Airway Complications After Deep or Awake Extubation
A Phase 4 study, sponsored by Massachusetts Eye and Ear Infirmary.
- Terminated
- Registry status
- Phase 4
- Development phase
- 92
- Enrollment target
NCT02162433 is a Phase 4 study that was terminated before completion, run by Massachusetts Eye and Ear Infirmary. The registered enrollment target is 92 participants.
The verdict
NCT02162433, a Phase 4 study, was terminated before completion, sponsored by Massachusetts Eye and Ear Infirmary.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 92 participants
- Enrollment target
Study Summary
The investigators aim to investigate the effect of dexmedetomidine on the perioperative respiratory complications in this patient population undergoing both awake and deep tracheal extubation.
Interventions
- DRUG Dexmedetomidine
- DRUG Normal Saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2015-03 |
| Est. Completion | 2018-04-23 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02162433
The ClinicalTrials.gov registry entry for NCT02162433 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts Eye and Ear Infirmary, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dexmedetomidine is the first listed.
NCT02162433 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02162433 about?
NCT02162433 is a clinical study titled "The Effect of Dexmedetomidine on Airway Complications After Deep or Awake Extubation". The investigators aim to investigate the effect of dexmedetomidine on the perioperative respiratory complications in this patient population undergoing both awake and deep tracheal extubation.
What is the current status of trial NCT02162433?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 92 participants. The study started on 2015-03. Estimated completion is 2018-04-23.
What interventions are being tested in trial NCT02162433?
The interventions under investigation include: Dexmedetomidine (DRUG), Normal Saline (DRUG).
Who is sponsoring clinical trial NCT02162433?
This trial is sponsored by Massachusetts Eye and Ear Infirmary, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.